WALTHAM, Mass.--(BUSINESS WIRE)--April 12, 2005--Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will release financial results for the quarter ended March 31, 2005 and hold a conference call with investors on Tuesday, April 26, 2005. The Company plans to hold the investor conference call, hosted by Bob Weiler, president and chief executive officer, and Rodger Weismann, senior vice president and chief financial officer, to discuss its first quarter financial results and its outlook for the second quarter of 2005. The call will be held on Tuesday, April 26, 2005, at 5:00 p.m. Eastern Time (ET).

The investor conference call will be available via live web cast on Phase Forward's web site at www.phasefoward.com under the tab "Investors". To participate by telephone, the domestic dial-in number is 800-435-1398 and the international dial-in is 617-614-4078. The access code is 38173027. Investors are advised to dial-in at least five minutes prior to the call to register. The web cast will be archived for thirty days: from 7:00 p.m. Tuesday, April 26, until 7:00 p.m. Thursday, May 26, 2005.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company helps pharmaceutical, biotechnology, and medical device companies bring needed drugs and therapies to market faster and more safely. Phase Forward offers proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER). Phase Forward products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 220 organizations worldwide including: AstraZeneca, Biogen Idec, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, GlaxoSmithKline, Guidant, Procter & Gamble, Quintiles, Sanofi-Aventis, Schering-Plough Research Institute, and Serono. Additional information about Phase Forward is available at www.phaseforward.com.

CONTACT: Public Relations
Phase Forward
Pam Sullivan, 781-902-4502
pam.sullivan@phaseforward.com
or
Investor Relations
Qorvis Communications
Karen Vahouny, 703-744-7809
kvahouny@qorvis.com
SOURCE: Phase Forward